Er-Kim Extends Exclusive Distribution Agreement with Ascendis Pharma A/S to Expand Commercialization of Its Endocrinology Portfolio to Eurasian Markets Er-Kim broadens drug distribution for novel rare endocrinology disease therapies in CEE and Eurasian markets